Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma – analyses of cases from two prospective randomized clinical trials

Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma – analyses of cases from two prospective randomized clinical trials

Background Research on prognostically relevant immunohistochemical markers in diffuse large B-cell lymphomas has mostly been performed on retrospectively collected clinical data. This is also true for immunohistochemical classifiers that are thought to reflect the cell-of-origin subclassification of...

Full description

Bibliographic Details
Main Authors: Heinz-Wolfram Bernd, Marita Ziepert, Christoph Thorns, Wolfram Klapper, Hans-Heinrich Wacker, Michael Hummel, Harald Stein, Martin-Leo Hansmann, German Ott, Andreas Rosenwald, Hans-Konrad Müller-Hermelink, Thomas F. E. Barth, Peter Möller, Sergio B. Cogliatti, Michael Pfreundschuh, Norbert Schmitz, Lorenz Trümper, Silvia Höller, Markus Löffler, Alfred C. Feller
Format: Article
Language:English
Published: Ferrata Storti Foundation 2009-11-01
Series:Haematologica
Online Access:https://haematologica.org/article/view/5408

Internet

https://haematologica.org/article/view/5408

Similar Items